Inventor
BARTHOLOMAEUS JOHANNES
DE32 patents
⚠️ This page may combine multiple inventors who share the name “BARTHOLOMAEUS JOHANNES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GRUENENTHAL GMBH
18 patentsUS6685964B1Feb 3, 2004
Opioid analgesics with controlled active substance release
GRUENENTHAL GMBH112 citations96
US6576260B2Jun 10, 2003
Sustained-release form of administration containing tramadol saccharinate
GRUENENTHAL GMBH53 citations96
US6558701B2May 6, 2003
Multilayer tablet for administering a fixed combination of tramadol and diclofenac
GRUENENTHAL GMBH59 citations96
US9629807B2Apr 25, 2017
Abuse-proofed dosage form
GRUENENTHAL GMBH21 citations94
US8383152B2Feb 26, 2013
Pharmaceutical dosage form
GRUENENTHAL GMBH78 citations93
US9675610B2Jun 13, 2017
Abuse-proofed dosage form
GRUENENTHAL GMBH17 citations92
US7906141B2Mar 15, 2011
Sustained-release, oral pharmaceutical forms of formulation
GRUENENTHAL GMBH28 citations92
US6291462B1Sep 18, 2001
Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
GRUENENTHAL GMBH35 citations91
US10369109B2Aug 6, 2019
Abuse-proofed dosage form
GRUENENTHAL GMBH5 citations84
US7897173B2Mar 1, 2011
Sustained-release, oral pharmaceutical formulations and methods of making and using same
GRUENENTHAL GMBH14 citations84
US7572463B2Aug 11, 2009
Oral dosage forms
GRUENENTHAL GMBH9 citations84
US10058548B2Aug 28, 2018
Abuse-proofed dosage form
GRUENENTHAL GMBH4 citations73
US8361506B2Jan 29, 2013
Fast release dosage forms for antibiotics
GRUENENTHAL GMBH3 citations58
US7669781B2Mar 2, 2010
Drinking straw comprising a reinforced section
GRUENENTHAL GMBH3 citations55
US11007156B2May 18, 2021
Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
GRUENENTHAL GMBH0 citations52
US7994382B2Aug 9, 2011
Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredient
GRUENENTHAL GMBH1 citations52
US7410965B2Aug 12, 2008
Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
GRUENENTHAL GMBH1 citations52
US7666860B2Feb 23, 2010
Melt-formulated, multi-particulate oral dosage form
GRUENENTHAL GMBH1 citations51
GRUENENTHAL CHEMIE
4 patentsUS7776314B2Aug 17, 2010
Abuse-proofed dosage system
GRUENENTHAL CHEMIE300 citations99
US7611730B2Nov 3, 2009
Tramadol-based medicament
GRUENENTHAL CHEMIE50 citations95
US6875447B2Apr 5, 2005
Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
GRUENENTHAL CHEMIE22 citations92
US7838034B2Nov 23, 2010
Intravenous pharmaceutical form of administration
GRUENENTHAL CHEMIE18 citations84
ARKENAU-MARIC ELISABETH
4 patentsUS8075872B2Dec 13, 2011
Abuse-proofed dosage form
ARKENAU-MARIC ELISABETH169 citations98
US8420056B2Apr 16, 2013
Abuse-proofed dosage form
ARKENAU-MARIC ELISABETH58 citations97
US8323889B2Dec 4, 2012
Process for the production of an abuse-proofed solid dosage form
ARKENAU-MARIC ELISABETH56 citations97
US8088322B2Jan 3, 2012
Method and device for ultrasound-pressing a tablet or a multiparticulate medicament
ARKENAU-MARIC ELISABETH2 citations57
BARTHOLOMAEUS JOHANNES
3 patentsUS8114383B2Feb 14, 2012
Abuse-proofed dosage form
BARTHOLOMAEUS JOHANNES284 citations98
US8133510B2Mar 13, 2012
Form of administration based on crosslinked hydrophilic polymers
BARTHOLOMAEUS JOHANNES4 citations55
US8173164B2May 8, 2012
Oral administration forms for administering a fixed tramadol and diclofenac combination
BARTHOLOMAEUS JOHANNES0 citations51